Neuromuscular refractoriness during blockage of transmission. A quantitative study

Area of Science:

• Anesthesiology
• Neuroscience
• Pharmacology

Background:

• Neuromuscular blocking agents are crucial in anesthesia.
• Understanding their effects on neuromuscular transmission refractoriness is vital for safe clinical practice.
• Suxamethonium and tubocurarine have different mechanisms of action.

Purpose of the Study:

• To investigate the impact of suxamethonium and tubocurarine on neuromuscular transmission refractoriness.
• To correlate the degree of neuromuscular block with changes in refractoriness.
• To differentiate the effects of depolarizing (suxamethonium) and non-depolarizing (tubocurarine) neuromuscular blockers.

Main Methods:

• Studied 21 anesthetized adult subjects with varying levels of neuromuscular block.
• Used twin supramaximal stimuli (4 ms apart) to assess neuromuscular refractoriness.
• Quantified refractoriness using the refractory fraction, measuring the decrement in response to the second stimulus.
• Determined the magnitude of neuromuscular block by the response to the first stimulus.

Main Results:

• At baseline (no block), neuromuscular transmission exhibited 23% refractoriness.
• Suxamethonium markedly increased refractoriness, reaching 0.69 at 50% block.
• Complete refractoriness was observed during 25-75% block with suxamethonium in 8 of 11 subjects.
• Tubocurarine did not significantly alter refractoriness; responses decreased proportionally with increasing block.

Conclusions:

• Suxamethonium significantly enhances neuromuscular transmission refractoriness, potentially leading to complete block even at partial blockade levels.
• Tubocurarine's effect on refractoriness differs, with responses decreasing in proportion to the induced neuromuscular block.
• These findings highlight distinct effects of different neuromuscular blocking agents on neuromuscular transmission dynamics.